Phospho-NFAT5 (S155) Antibody

What is NFAT5 and why is the S155 phosphorylation site significant?

NFAT5 (Nuclear Factor of Activated T-cells 5), also known as TONEBP (Tonicity-responsive enhancer-binding protein), is a member of the Rel family of transcription factors. Unlike other NFAT proteins, NFAT5 lacks docking sites for phosphatase calcineurin, making the calcium/calcineurin signaling cascade dispensable for its activation and nuclear localization .

The S155 phosphorylation site is particularly significant because it plays a crucial role in regulating NFAT5's subcellular localization. Research has demonstrated that increasing phosphorylation at S155 and S158 during hypotonic conditions reduces the nuclear accumulation of NFAT5 . This contrasts with phosphorylation at other sites such as Y143 and T135, which enhance nuclear localization. Understanding S155 phosphorylation provides critical insights into the mechanisms controlling NFAT5's activity and function in different cellular contexts.

What experimental applications are recommended for Phospho-NFAT5 (S155) antibody?

The Phospho-NFAT5 (S155) antibody has been validated for several key applications:

For Western blotting, researchers should optimize protein loading (typically 20-40 μg of total protein) and ensure complete transfer to the membrane. When designing experiments, it's important to include appropriate positive controls (cells exposed to hypotonic conditions) and negative controls (cells treated with phosphatase inhibitors) to validate signal specificity .

How should samples be prepared for optimal detection of phosphorylated NFAT5 at S155?

For optimal detection of phosphorylated NFAT5 at S155, sample preparation is critical:

• Cell lysis: Use a buffer containing phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) to prevent dephosphorylation during sample processing.

• Tissue samples: Flash-freeze immediately after collection and process rapidly to minimize phosphorylation changes.

• Subcellular fractionation: When examining nuclear vs. cytoplasmic distribution, use gentle lysis methods to preserve phosphorylation status while separating compartments.

• Stimulation conditions: For positive controls, consider hypotonic treatments which increase S155 phosphorylation .

• Storage: Aliquot samples and store at -80°C to avoid freeze-thaw cycles that may affect phosphorylation status .

Remember that phosphorylation states can change rapidly, so consistent sample handling is essential for reproducible results.

What are appropriate positive and negative controls when using Phospho-NFAT5 (S155) antibody?

Establishing proper controls is essential for interpreting results with phospho-specific antibodies:

Positive Controls:

• Cells exposed to hypotonic conditions, which increase S155 phosphorylation

• Recombinant NFAT5 protein phosphorylated at S155

• Cell types known to express high levels of phosphorylated NFAT5 (e.g., kidney medulla cells)

Negative Controls:

• Samples treated with lambda phosphatase to remove phosphate groups

• NFAT5 knockout or knockdown cells/tissues

• Blocking peptide experiments using the immunizing peptide

• S155A mutant NFAT5 (where serine is replaced with alanine to prevent phosphorylation)

Including these controls helps validate antibody specificity and ensures accurate interpretation of experimental results.

How does S155 phosphorylation regulate NFAT5 function compared to other phosphorylation sites?

NFAT5 undergoes complex regulation through multiple phosphorylation events at different sites. The functional consequences vary significantly:

S155 phosphorylation appears to act as a negative regulator of NFAT5 nuclear accumulation, whereas Y143 phosphorylation promotes nuclear localization through c-Abl kinase and phospholipase C gamma 1 . This suggests a balance between activating and inhibitory phosphorylation events that tightly control NFAT5's transcriptional activity.

Research investigating the interplay between these phosphorylation sites requires selective inhibitors, phospho-specific antibodies, and potentially phosphomimetic or phospho-deficient mutants to dissect their individual contributions to NFAT5 function.

What signaling pathways regulate S155 phosphorylation of NFAT5 in different cellular contexts?

NFAT5 phosphorylation is regulated by multiple signaling pathways that respond to various cellular stresses:

To investigate these pathways, researchers should consider using selective kinase inhibitors (e.g., dasatinib for c-Abl kinases) and phosphatase inhibitors while monitoring S155 phosphorylation levels under different cellular stresses.

How does S155 phosphorylation affect NFAT5's role in biomolecular condensate formation?

Recent research has revealed that NFAT5 forms biomolecular condensates in response to hypertonic and ionic stress through its C-terminal prion-like domain (PLD) . The relationship between S155 phosphorylation and condensate formation represents an exciting research frontier:

• Condensate dynamics: The NFAT5 PLD is sufficient to form condensates and activate transcription of target genes in response to ionic stress . Phosphorylation at S155 may modulate the biophysical properties of these condensates.

• Regulatory mechanisms: Since S155 phosphorylation reduces nuclear accumulation of NFAT5 , it may also affect the assembly or disassembly of nuclear condensates.

• Experimental approaches: To study this relationship, researchers could:

  • Use live-cell imaging with fluorescently tagged NFAT5 and phospho-mimetic (S155D/E) or phospho-dead (S155A) mutants

  • Employ FRAP (Fluorescence Recovery After Photobleaching) to analyze condensate dynamics under conditions that modify S155 phosphorylation

  • Use 1,6-hexanediol treatment, which disrupts condensate formation and inhibits NFAT5 target gene transcription

Understanding this relationship could reveal how phosphorylation regulates phase separation as a mechanism for transcriptional control.

How can the Phospho-NFAT5 (S155) antibody be used to investigate NFAT5's role in disease mechanisms?

NFAT5 is implicated in various pathological conditions, and the Phospho-NFAT5 (S155) antibody can provide valuable insights:

• Kidney disorders: NFAT5 is a master regulator of gene expression in kidney collecting ducts, and loss of NFAT5 function induces kidney injury-like phenotypes . Researchers can use the antibody to examine how S155 phosphorylation status changes in kidney disease models.

• Immune system dysregulation: NFAT5 amplifies antipathogen responses by enhancing chromatin accessibility at promoter regions of multiple TLR4-responsive genes . The antibody can help determine if S155 phosphorylation modulates this immune function.

• Cancer biology: NFAT5 is implicated in glioblastoma, hepatoma, and other cancers through various signaling pathways . Researchers can investigate whether aberrant S155 phosphorylation contributes to oncogenic mechanisms.

• Neurological disorders: miR-29c-3p suppresses inflammasome activation by targeting NFAT5, potentially influencing inflammatory responses in Parkinson's disease . The antibody could help examine how S155 phosphorylation affects this pathway.

Methodologically, researchers should combine the antibody with tissue microarrays, patient samples, and animal models, comparing phosphorylation patterns between normal and diseased states while correlating with clinical outcomes.

What techniques can be used to validate the specificity of Phospho-NFAT5 (S155) antibody in different experimental systems?

Validating antibody specificity is critical for phospho-specific antibodies. Researchers should consider:

• Genetic approaches:

  • CRISPR/Cas9-mediated mutation of S155 to alanine (S155A) should eliminate antibody recognition

  • siRNA/shRNA knockdown of NFAT5 should reduce or eliminate the signal

  • Use of NFAT5 knockout cells or tissues (e.g., NFAT5-/- cells)

• Biochemical validation:

  • Lambda phosphatase treatment to remove phosphate groups

  • Immunoprecipitation followed by mass spectrometry to confirm the exact phosphorylation site

  • Peptide competition assays using the immunizing peptide (phosphorylated and non-phosphorylated versions)

• Signal correlation:

  • Compare signals between Phospho-NFAT5 (S155) antibody and total NFAT5 antibody

  • Verify expected changes in S155 phosphorylation under known regulatory conditions (e.g., hypotonic vs. hypertonic)

  • Use site-directed mutagenesis to create phosphomimetic (S155D/E) or phospho-dead (S155A) NFAT5 mutants

These validation approaches ensure that experimental observations truly reflect S155 phosphorylation status rather than non-specific binding.

How can researchers quantitatively assess changes in NFAT5 S155 phosphorylation in response to cellular stresses?

To quantitatively measure changes in S155 phosphorylation:

• Western blot analysis:

  • Use both phospho-specific (S155) and total NFAT5 antibodies

  • Calculate the ratio of phosphorylated to total NFAT5

  • Include loading controls (e.g., β-actin, GAPDH)

  • Use quantitative software (ImageJ, etc.) for densitometry

• Immunofluorescence quantification:

  • Perform z-stack imaging using the Phospho-NFAT5 (S155) antibody

  • Quantify nuclear vs. cytoplasmic signal using CellProfiler or ImageJ

  • Count nuclear puncta using automated thresholding functions

  • Co-stain with DAPI to identify nuclear boundaries

• High-throughput approaches:

  • Phospho-flow cytometry for single-cell analysis

  • ELISA-based quantification (1:10000 dilution recommended)

  • Phospho-proteomics using mass spectrometry for global phosphorylation analysis

• Time-course experiments:

  • Monitor S155 phosphorylation changes over time following stress application

  • Compare with known NFAT5 target gene expression (e.g., aldose reductase, BGT1, SMIT, TauT)

This quantitative data will provide insights into the kinetics and magnitude of S155 phosphorylation in response to different cellular conditions.